InsidersTradesSigma
Explore the complete record of transactions filed by Palantoni Frank, Director. Officer active across 1 companies, notably Lexicon Pharmaceuticals, INC.. Aggregated, 1 filings have been recorded. The latest transaction was disclosed on 30 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Frank Palantoni is a Board Member at Lexicon Pharmaceuticals, Inc. He brings valuable expertise in strategy and business development to the board, contributing to the guidance of the company's strategic decisions.